Tag: significantly

(MedPage Today) -- DENVER -- Treatment-resistant dermatomyositis improved significantly with the investigational TYK2/JAK1 inhibitor brepocitinib, according to a randomized trial. ...

It says weak tax systems are allowing the harmful products to remain cheap while health systems face mounting financial pressure ...